Vedvick TS[au] - Search Results

Year	Number of Results
1968	1
1974	4
1975	2
1976	1
1977	1
1978	2
1979	1
1980	3
1981	1
1983	1
1986	1
1987	2
1988	1
1989	1
1990	1
1991	3
1992	1
1993	5
1995	1
1997	1
1998	1
2000	2
2001	4
2002	1
2003	2
2006	1
2008	3
2009	5
2010	4
2011	6
2012	3
2013	8
2014	6
2015	2
2016	2
2017	2
2018	1
2022	0

1

Gene expression in yeast: Pichia pastoris.

Vedvick TS. Vedvick TS. Curr Opin Biotechnol. 1991 Oct;2(5):742-5. doi: 10.1016/0958-1669(91)90045-7. Curr Opin Biotechnol. 1991. PMID: 1367728 Review.

2

Recent advances in the expression of foreign genes in Pichia pastoris.

Cregg JM, Vedvick TS, Raschke WC. Cregg JM, et al. Among authors: vedvick ts. Biotechnology (N Y). 1993 Aug;11(8):905-10. doi: 10.1038/nbt0893-905. Biotechnology (N Y). 1993. PMID: 7763913 Review.

3

Development of a thermostable nanoemulsion adjuvanted vaccine against tuberculosis using a design-of-experiments approach.

Kramer RM, Archer MC, Orr MT, Dubois Cauwelaert N, Beebe EA, Huang PD, Dowling QM, Schwartz AM, Fedor DM, Vedvick TS, Fox CB. Kramer RM, et al. Among authors: vedvick ts. Int J Nanomedicine. 2018 Jun 26;13:3689-3711. doi: 10.2147/IJN.S159839. eCollection 2018. Int J Nanomedicine. 2018. PMID: 29983563 Free PMC article.

4

Working together: interactions between vaccine antigens and adjuvants.

Fox CB, Kramer RM, Barnes V L, Dowling QM, Vedvick TS. Fox CB, et al. Among authors: vedvick ts. Ther Adv Vaccines. 2013 May;1(1):7-20. doi: 10.1177/2051013613480144. Ther Adv Vaccines. 2013. PMID: 24757512 Free PMC article.

5

Physical stabilization of Norwalk virus-like particles.

Kissmann J, Ausar SF, Foubert TR, Brock J, Switzer MH, Detzi EJ, Vedvick TS, Middaugh CR. Kissmann J, et al. Among authors: vedvick ts. J Pharm Sci. 2008 Oct;97(10):4208-18. doi: 10.1002/jps.21315. J Pharm Sci. 2008. PMID: 18300304

6

Lyophilization of an Adjuvanted Mycobacterium tuberculosis Vaccine in a Single-Chamber Pharmaceutical Cartridge.

Barnes V L, Fedor DM, Williams S, Dowling QM, Archer MC, Cloutier S, Parker S, Vedvick TS, Fox CB, Kramer RM. Barnes V L, et al. Among authors: vedvick ts. AAPS PharmSciTech. 2017 Aug;18(6):2077-2084. doi: 10.1208/s12249-016-0688-7. Epub 2016 Dec 20. AAPS PharmSciTech. 2017. PMID: 28000085

7

Optimized subunit vaccine protects against experimental leishmaniasis.

Bertholet S, Goto Y, Carter L, Bhatia A, Howard RF, Carter D, Coler RN, Vedvick TS, Reed SG. Bertholet S, et al. Among authors: vedvick ts. Vaccine. 2009 Nov 23;27(50):7036-45. doi: 10.1016/j.vaccine.2009.09.066. Epub 2009 Sep 26. Vaccine. 2009. PMID: 19786136 Free PMC article.

8

In vitro evaluation of TLR4 agonist activity: formulation effects.

Misquith A, Fung HW, Dowling QM, Guderian JA, Vedvick TS, Fox CB. Misquith A, et al. Among authors: vedvick ts. Colloids Surf B Biointerfaces. 2014 Jan 1;113:312-9. doi: 10.1016/j.colsurfb.2013.09.006. Epub 2013 Sep 19. Colloids Surf B Biointerfaces. 2014. PMID: 24121074 Free PMC article.

9

Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.

Fox CB, Baldwin SL, Vedvick TS, Angov E, Reed SG. Fox CB, et al. Among authors: vedvick ts. Clin Vaccine Immunol. 2012 Oct;19(10):1633-40. doi: 10.1128/CVI.00235-12. Epub 2012 Aug 15. Clin Vaccine Immunol. 2012. PMID: 22896687 Free PMC article.

10

Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization.

Orr MT, Kramer RM, Barnes L 5th, Dowling QM, Desbien AL, Beebe EA, Laurance JD, Fox CB, Reed SG, Coler RN, Vedvick TS. Orr MT, et al. Among authors: vedvick ts. J Control Release. 2014 Mar 10;177:20-6. doi: 10.1016/j.jconrel.2013.12.025. Epub 2013 Dec 29. J Control Release. 2014. PMID: 24382398 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results